This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert A. Schumer, MD, PhD; Steven M. Podos, MD

Arch Ophthalmol. 1994;112(1):37-44.

Abstract
Contemporary concepts of open angle glaucoma suggest that the current emphasis on reduction of elevated intraocular pressure could be augmented by other therapeutic approaches. In this article, we describe significant recent developments in the molecular and cellular biology and neuropharmacology of nerve damage that are likely, in coming years, to suggest new therapeutic approaches to the management of glaucoma. These developments may lead to the achievement of pharmacologic protection of the optic nerve from damage or possibly promotion of reversal of damage. We review selected studies of excitotoxins and N-methyl-D-aspartate receptor antagonists, Ca²⁺-induced damage and calcium channel blockers, the intracellular messenger nitric oxide and its perturbation, free-radical damage and scavengers, nerve regeneration, and growth factors. Several basic research questions are posed, answers to which may transform our concepts of glaucoma therapy.

Author Affiliations
From the Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY. The authors have no financial or proprietary interest in the compounds mentioned in this article. Dr Podos is a consultant to Allergan Inc, Irvine, Calif, Alcon Laboratories Inc, Fort Worth, Tex, and Pharmos Corp, New York.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Inducible Nitric Oxide Synthase in Glaucomatous Optic Neuropathy and Pressure-Induced Optic Nerve Damage
Pang et al.
IOVS 2005;46:1313-1321.
ABSTRACT | FULL TEXT  

Functional and Structural Analysis of the Visual System in the Rhesus Monkey Model of Optic Nerve Head Ischemia
Brooks et al.
IOVS 2004;45:1830-1840.
ABSTRACT | FULL TEXT  

The Role of Apolipoprotein E Gene Polymorphisms in Primary Open-angle Glaucoma
Ressiniotis et al.
Arch Ophthalmol 2004;122:258-261.
ABSTRACT | FULL TEXT  

Antioxidant Intake and Primary Open-Angle Glaucoma: A Prospective Study
Kang et al.
Am J Epidemiol 2003;158:337-346.
ABSTRACT | FULL TEXT  

Clinical Factors Associated With Progression of Glaucomatous Optic Disc Damage in Treated Patients
Tezel et al.
Arch Ophthalmol 2001;119:813-818.
ABSTRACT | FULL TEXT  

Association of Demographic, Familial, Medical, and Ocular Factors With Intraocular Pressure
Weih et al.
Arch Ophthalmol 2001;119:875-880.
ABSTRACT | FULL TEXT  

Serum Autoantibody against Glutathione S-Transferase in Patients with Glaucoma
Yang et al.
IOVS 2001;42:1273-1276.
ABSTRACT | FULL TEXT  

Optic Nerve Transection in Monkeys May Result in Secondary Degeneration of Retinal Ganglion Cells
Levkovitch–Verbin et al.
IOVS 2001;42:975-982.
ABSTRACT | FULL TEXT  

The Photopic Negative Response of the Flash Electroretinogram in Primary Open Angle Glaucoma
Viswanathan et al.
IOVS 2001;42:514-522.
ABSTRACT | FULL TEXT  

The Combined Effect of Brain-Derived Neurotrophic Factor and a Free Radical Scavenger in Experimental Glaucoma
Ko et al.
IOVS 2000;41:2967-2971.
ABSTRACT | FULL TEXT  

The Uniform Field and Pattern ERG in Macaques with Experimental Glaucoma: Removal of Spiking Activity
Viswanathan et al.
IOVS 2000;41:2797-2810.
ABSTRACT | FULL TEXT  

Glaucoma in Primates: Cytochrome Oxidase Reactivity in Parvo- and Magnocellular Pathways
Crawford et al.
IOVS 2000;41:1791-1802.
ABSTRACT | FULL TEXT  

Self-destructive and Self-protective Processes in the Damaged Optic Nerve: Implications for Glaucoma
Schwartz and Yoles
IOVS 2000;41:349-351.
FULL TEXT  

Is Neuroprotection a Viable Therapy for Glaucoma?
Weinreb and Levin
Arch Ophthalmol 1999;117:1540-1544.
ABSTRACT | FULL TEXT  

Ganglion Cell Losses Underlying Visual Field Defects from Experimental Glaucoma
Harwerth et al.
IOVS 1999;40:2242-2250.
ABSTRACT | FULL TEXT  

Nitric-oxide synthase and neurodegeneration/neuroprotection
Kaufman
Proc. Natl. Acad. Sci. USA 1999;96:9455-9456.
FULL TEXT  

Elevation of Intraocular Glutamate Levels in Rats With Partial Lesion of the Optic Nerve
Yoles and Schwartz
Arch Ophthalmol 1998;116:906-910.
ABSTRACT | FULL TEXT  

Elevated Glutamate Levels in the Vitreous Body of Humans and Monkeys With Glaucoma
Dreyer et al.
Arch Ophthalmol 1996;114:299-305.
ABSTRACT